Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|June 20, 2020
Assembling Pharma Resources to Tackle Diseases of Underserved PopulationsDale J Kempf, Kennan C MarshChemistry & Biology|October 19, 2004
An 'inside-the-box' approach to drug resistanceKent D Stewart, Dale J KempfThe Journal of Infectious Diseases|May 18, 2005
Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavirMartin S King, Scott C Brun, Dale J KempfJournal of Clinical Microbiology|September 15, 2004
Complementation in cells cotransfected with a mixture of wild-type and mutant human immunodeficiency virus (HIV) influences the replication capacities and phenotypes of mutant variants in a single-cycle HIV resistance assayHongmei Mo, Liangjun Lu, Ron Pithawalla, et al.Journal of Virology|February 26, 2005
Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlatesHongmei Mo, Martin S King, Kathryn King, et al.Acta Crystallographica. Section F, Structural Biology Communications|March 15, 2017
Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5Anup K Upadhyay, Matthew Cyr, Kenton Longenecker, et al.Antimicrobial Agents and Chemotherapy|November 15, 2006
Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replicationHongmei Mo, Neil Parkin, Kent D Stewart, et al.Antiviral Research|August 21, 2003
Characterization of resistant HIV variants generated by in vitro passage with lopinavir/ritonavirHongmei Mo, Liangjun Lu, Tatyana Dekhtyar, et al.Antimicrobial Agents and Chemotherapy|June 19, 2002
In vitro antiviral interaction of lopinavir with other protease inhibitorsAkhteruzzaman Molla, Hongmei Mo, Sudthida Vasavanonda, et al.Antimicrobial Agents and Chemotherapy|July 27, 2004
Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavirDean Hickman, Sudthida Vasavanonda, George Nequist, et al.Pageof 8